» Articles » PMID: 34233724

Severe Hypercalcemia Associated with Hypophosphatemia in Very Premature Infants: a Case Report

Overview
Journal Ital J Pediatr
Publisher Biomed Central
Specialty Pediatrics
Date 2021 Jul 8
PMID 34233724
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Severe hypercalcemia is rare in newborns; even though often asymptomatic, it may have important sequelae. Hypophosphatemia can occur in infants experiencing intrauterine malnutrition, sepsis and early high-energy parenteral nutrition (PN) and can cause severe hypercalcemia through an unknown mechanism. Monitoring and supplementation of phosphate (PO4) and calcium (Ca) in the first week of life in preterm infants are still debated.

Case Presentation: We report on a female baby born at 29 weeks' gestation with intrauterine growth retardation (IUGR) experiencing sustained severe hypercalcemia (up to 24 mg/dl corrected Ca) due to hypophosphatemia while on phosphorus-free PN. Hypercalcemia did not improve after hyperhydration and furosemide but responded to infusion of PO4. Eventually, the infant experienced symptomatic hypocalcaemia (ionized Ca 3.4 mg/dl), likely exacerbated by contemporary infusion of albumin. Subsequently, a normalization of both parathyroid hormone (PTH) and alkaline phosphatase (ALP) was observed.

Conclusions: Although severe hypercalcemia is extremely rare in neonates, clinicians should be aware of the possible occurrence of this life-threatening condition in infants with or at risk to develop hypophosphatemia. Hypophosphatemic hypercalcemia can only be managed with infusion of PO4, with strict monitoring of Ca and PO4 concentrations.

Citing Articles

"Calcium-Phosphorus-Magnesium " and the Metabolic Issue of Newborns Undergoing Parenteral Nutrition: Is It Time to Change Our Perspectives?.

Notarbartolo V, Carta M, Badiane B, Puccio G, Corsello G, Giuffre M Nutrients. 2025; 17(5).

PMID: 40077645 PMC: 11901507. DOI: 10.3390/nu17050775.


New insights in pediatrics in 2021: choices in allergy and immunology, critical care, endocrinology, gastroenterology, genetics, haematology, infectious diseases, neonatology, neurology, nutrition, palliative care, respiratory tract illnesses and....

Caffarelli C, Santamaria F, Piro E, Basilicata S, Delle Cave V, Cipullo M Ital J Pediatr. 2022; 48(1):189.

PMID: 36435791 PMC: 9701393. DOI: 10.1186/s13052-022-01374-8.

References
1.
Rodd C, Goodyer P . Hypercalcemia of the newborn: etiology, evaluation, and management. Pediatr Nephrol. 1999; 13(6):542-7. DOI: 10.1007/s004670050654. View

2.
Ichikawa G, Watabe Y, Suzumura H, Sairenchi T, Muto T, Arisaka O . Hypophosphatemia in small for gestational age extremely low birth weight infants receiving parenteral nutrition in the first week after birth. J Pediatr Endocrinol Metab. 2012; 25(3-4):317-21. DOI: 10.1515/jpem-2011-0485. View

3.
Mulla S, Stirling S, Cowey S, Close R, Pullan S, Howe R . Severe hypercalcaemia and hypophosphataemia with an optimised preterm parenteral nutrition formulation in two epochs of differing phosphate supplementation. Arch Dis Child Fetal Neonatal Ed. 2017; 102(5):F451-F455. DOI: 10.1136/archdischild-2016-311107. View

4.
Bushinsky D, Monk R . Electrolyte quintet: Calcium. Lancet. 1998; 352(9124):306-11. DOI: 10.1016/s0140-6736(97)12331-5. View

5.
Fenton T, Lyon A, Rose M . Cord blood calcium, phosphate, magnesium, and alkaline phosphatase gestational age-specific reference intervals for preterm infants. BMC Pediatr. 2011; 11:76. PMC: 3179922. DOI: 10.1186/1471-2431-11-76. View